Efficacy and safety of COVID-19 vaccines in children aged 5 to 11 years
DOI:
https://doi.org/10.52611/confluencia.2026.1916Keywords:
COVID-19 vaccine, Children, Adolescents, Safety, EfficacyAbstract
Introduction: COVID-19 is typically mild in children, but severe cases, such as multisystem inflammatory syndrome, can occur. Vaccination is the primary preventive strategy. Methodology: A literature review was conducted using a structured search (2020–2025) with MeSH/DeCS terms. Systematic reviews, meta-analyses, randomized controlled trials, and large-scale cohort studies that evaluated the safety and efficacy of vaccinations were selected. Result: mRNA vaccines show an initial efficacy of 90% against symptomatic disease and 96% against severe disease, with efficacy decreasing against the Omicron variant but maintaining high protection against hospitalizations. Adverse effects are mild and self-limiting (6-10%); the risk of myocarditis is low in children under 12 years of age, at 1,8 cases per million. In Chile, the inactivated CoronaVac vaccine demonstrated 64,6% effectiveness against the Omicron variant in preventing hospitalizations and 69% effectiveness in preventing Intensive Care Units admissions. Discussion: The risk-benefit balance favors childhood immunization compared to the risks of natural infection and its sequelae. Conclusions: Pediatric vaccination against COVID-19 is a safe and effective intervention. Immunization policies should be adapted to local epidemiology while ensuring equity.
References
1. Piechotta V, Siemens W, Thielemann I, Toews M, Koch J, Vygen-Bonnet S, et al. Safety and effectiveness of vaccines against COVID-19 in children aged 5-11 years: a systematic review and meta-analysis. Lancet Child Adolesc Health [Internet]. 2023 [citado el 1 de agosto 2026];7(6):379-91. Disponible en: http://dx.doi.org/10.1016/S2352-4642(23)00078-0
2. Wen J, Du X, Li A, Zhang S, Shen S, Zhang Z, et al. Dilemmas and options for COVID-19 vaccination in children. Ital J Pediatr [Internet]. 2023 [citado el 1 de agosto 2026];49(1):103. Disponible en: http://dx.doi.org/10.1186/s13052-023-01513-9
3. da Fonseca Lima EJ, Leite RD. COVID-19 vaccination in children: a public health priority. J Pediatr (Rio J) [Internet]. 2023 [citado el 1 de agosto 2026];99:S28-S36. Disponible en: http://dx.doi.org/10.1016/j.jped.2022.11.006
4. Chi WY, Li YD, Huang HC, Chan TEH, Chow SY, Su JH, et al. COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. J Biomed Sci [Internet]. 2022 [citado el 1 de agosto 2026];29(1):82. Disponible en: http://dx.doi.org/10.1186/s12929-022-00853-8
5. Jara A, Undurraga EA, Zubizarreta JR, González C, Acevedo J, Pizarro A, et al. Effectiveness of CoronaVac in children 3-5 years of age during the SARS-CoV-2 Omicron outbreak in Chile. Nat Med [Internet]. 2022 [citado el 1 de agosto 2026];28(7):1377-80. Disponible en: http://dx.doi.org/10.1038/s41591-022-01874-4
6. Howard-Jones AR, Bowen AC, Danchin M, Koirala A, Sharma K, Yeoh DK, et al. COVID‐19 in children: I. Epidemiology, prevention and indirect impacts. J Paediatr Child Health [Internet]. 2022 [citado el 1 de agosto 2026];58(1):39-45. Disponible en: http://dx.doi.org/10.1111/jpc.15791
7. Jantarabenjakul W, Chantasrisawad N, Nantanee R, Ganguli S, Puthanakit T. Global COVID-19 Vaccination in Infants and Children: Effectiveness, Safety, and Challenges. Asian Pac J Allergy Immunol [Internet]. 2023 [citado el 1 de agosto 2026];41(4):292-303. Disponible en: https://doi.org/10.12932/ap-300423-1596
8. Howard-Jones AR, Burgner DP, Crawford NW, Goeman E, Gray PE, Hsu P, et al. COVID‐19 in children. II: Pathogenesis, disease spectrum and management. J Paediatr Child Health [Internet]. 2022 [citado el 1 de agosto 2026];58(1):46-53. Disponible en: http://dx.doi.org/10.1111/jpc.15811
9. Sun YK, Wang C, Lin PQ, Hu L, Ye J, Gao ZG, et al. Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives. World J Pediatr [Internet]. 2024 [citado el 1 de agosto 2026];20(4):307-24. Disponible en: http://dx.doi.org/10.1007/s12519-023-00790-y
10. Azeem M, Cancemi P, Mukhtar F, Marino S, Peri E, Di Prima G, et al. Efficacy and limitations of SARS-CoV-2 vaccines - A systematic review. Life Sci [Internet]. 2025 [citado el 1 de agosto 2026];371:123610. Disponible en: http://dx.doi.org/10.1016/j.lfs.2025.123610
11. Munro APS, Jones CE, Faust SN. Vaccination against COVID-19 - risks and benefits in children. Eur J Pediatr [Internet]. 2024 [citado el 1 de agosto 2026];183(3):1107-12. Disponible en: http://dx.doi.org/10.1007/s00431-023-05380-8
12. Lv M, Luo X, Shen Q, Lei R, Liu X, Liu E, et al. Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review. Vaccines (Basel) [Internet]. 2021 [citado el 1 de agosto 2026];9(10):1102. Disponible en: http://dx.doi.org/10.3390/vaccines9101102
13. Tian F, Yang R, Chen Z. Safety and efficacy of COVID-19 vaccines in children and adolescents: A systematic review of randomized controlled trials. J Med Virol [Internet]. 2022 [citado el 1 de agosto 2026];94(10):4644-53. Disponible en: http://dx.doi.org/10.1002/jmv.27940
14. Hu YH, Ding Y, Li LW, Cheng J, Cai YH. Evaluation of vaccine effectiveness of mRNA COVID-19 vaccines in children: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci [Internet]. 2024 [citado el 1 de agosto 2026];28(6):2584-92. Disponible en: http://dx.doi.org/10.26355/eurrev_202403_35764
15. Fayad D, Frenck RW Jr. COVID-19 Vaccines in Children. J Clin Med [Internet]. 2023 [citado el 1 de agosto 2026];13(1):87. Disponible en: https://doi.org/10.3390/jcm13010087
16. Hart JD, Ong DS, Chokephaibulkit K, Ong-Lim AT, Vereti I, Crawford NW, et al. Considerations for vaccinating children against COVID-19. BMJ Paediatr Open [Internet]. 2023 [citado el 1 de agosto 2026];7(1):e001964. Disponible en: http://dx.doi.org/10.1136/bmjpo-2023-001964
17. Jara A, Undurraga EA, Flores JC, Zubizarreta JR, González C, Pizarro A, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study. Lancet Reg Health Am [Internet]. 2023 [citado el 1 de agosto 2026];21:100487. Disponible en: http://dx.doi.org/10.1016/j.lana.2023.100487
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Revista Confluencia

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.



